Original Research

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib Plus Humanized Programmed Death Receptor-1 in Patients with High-Risk Advanced Hepatocellular Carcinoma: A Real-World Study

Chang X, Wu H, Ning S, Li X, Xie Y, Shao W, Yu J

Journal of Hepatocellular Carcinoma 2023, 10:1497-1509

Published Date: 6 September 2023